Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04286490Not ApplicableCompleted

Prone Position and Renal Resistive Index

Role: collaborator

NCT03545997Phase 3Terminated

Montelukast for Patients With Obstructive Sleep Apnea Syndrome

Role: collaborator

NCT02264431Unknown

Severe Obesity Outcome Network Cohort (SOON)

Role: collaborator

All 3 trials loaded